Our results conclude that MMP2 (rs2285053) is associated with an increased risk of breast cancer, while MMP9 (rs3787268) polymorphisms may be correlated with a reduced risk of breast cancer in Bangladeshi females. Here, MMP9 is linked to breast carcinoma.